Nuvectis Pharma, Inc. Common Stock

NVCTNASDAQ • USD
7.69 USD
↗ 0.13 (1.71%)🟢LIVE (AS OF 01:16 PM EDT)
🟢Market: OPEN
Open?$7.58
High?$7.88
Low?$7.55
Prev. Close?$7.56
Volume?34.7K
Avg. Volume?55.4K
VWAP?$7.75
Rel. Volume?0.63x
Bid / Ask
Bid?$7.70 × 100
Ask?$9.95 × 4.9K
Spread?$2.25
Midpoint?$8.83
Valuation & Ratios
Market Cap?200.3M
Shares Out?26.5M
Float?15.5M
Float %?58.4%
P/E Ratio?N/A
P/B Ratio?10.88
EPS?-$1.09
Dividend?0.00%
Ex-Dividend?N/A
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...
Financial Health
Current Ratio?2.38Strong
Quick Ratio?2.38Strong
Cash Ratio?2.38Strong
Debt/Equity?0.00Low
ValuationFAIRLY VALUED
Score
67/100
P/E?
N/A▾
P/B?
10.88HIGH▾
P/S?
N/A▾
P/FCF?
N/A▾
EV/EBITDA?
-6.1CHEAP▾
EV/Sales?
N/A▾
Returns & Efficiency
ROE?
-156.8%WEAK▾
ROA?
-91.1%WEAK▾
Cash Flow & Enterprise
FCF?N/A
Enterprise Value?$168.6M
Related Companies
Loading...
News
Profile
Nuvectis Pharma Inc is a biopharmaceutical company. The company is engaged in the development of precision medicines for the treatment of serious conditions of unmet medical needs in oncology. It operates with one segment, focused on the development of novel targeted small molecule therapeutics for the treatment of cancer in genetically defined patient populations. Its pipeline products include NXP800, NXP900.
Employees
13
Market Cap
200.3M
Industry
PHARMACEUTICAL PREPARATIONS
Website
www.nuvectis.com
Listed
2022-02-04
Address
1 BRIDGE PLAZA, SUITE 275
FORT LEE, NJ 07024
Phone: 360-837-7232
MarketsMoversWatchlist